ArticleFrontiers in immunology2023

Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies.

Yijun Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.